Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 19, 2019

SELL
$52.6 - $63.29 $335,062 - $403,157
-6,370 Closed
0 $0
Q1 2019

Apr 24, 2019

BUY
$39.99 - $53.48 $24,233 - $32,408
606 Added 10.51%
6,370 $337,000
Q4 2018

Jan 23, 2019

BUY
$31.54 - $46.67 $181,796 - $269,005
5,764 New
5,764 $237,000

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Jgp Global Gestao De Recursos Ltda. Portfolio

Follow Jgp Global Gestao De Recursos Ltda. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

News

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.